-
1
-
-
0028114985
-
The implications of angiogenesis for the biology and therapy of cancer metastasis
-
DOI 10.1016/0092-8674(94)90187-2
-
Fidler, I. J. & Ellis, L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 79, 185-188 (1994). (Pubitemid 24324908)
-
(1994)
Cell
, vol.79
, Issue.2
, pp. 185-188
-
-
Fidler, I.J.1
Ellis, L.M.2
-
2
-
-
0030576517
-
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
-
DOI 10.1016/S0092-8674(00)80108-7
-
Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86, 353-364 (1996). (Pubitemid 26272076)
-
(1996)
Cell
, vol.86
, Issue.3
, pp. 353-364
-
-
Hanahan, D.1
Folkman, J.2
-
3
-
-
43249095919
-
Tumor angiogenesis
-
DOI 10.1056/NEJMra0706596
-
Kerbel, R. S. Tumor angiogenesis. N. Eng. J. Med. 358, 2039-2049 (2008). (Pubitemid 351656458)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.19
, pp. 2039-2049
-
-
Kerbel, R.S.1
-
4
-
-
47949089077
-
VEGF-targeted therapy: Mechanisms of anti-tumour activity
-
Ellis, L. M. & Hicklin, D. J. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat. Rev. Cancer. 8, 579-591 (2008).
-
(2008)
Nat. Rev. Cancer.
, vol.8
, pp. 579-591
-
-
Ellis, L.M.1
Hicklin, D.J.2
-
5
-
-
77953988924
-
Targeting the tumor vasculature: Insights from physiological angiogenesis
-
Chung, A. S., Lee, J. & Ferrara, N. Targeting the tumor vasculature: insights from physiological angiogenesis. Nat. Rev. Cancer. 10, 505-514 (2010).
-
(2010)
Nat. Rev. Cancer.
, vol.10
, pp. 505-514
-
-
Chung, A.S.1
Lee, J.2
Ferrara, N.3
-
6
-
-
0037699954
-
The biology of VEGF and its receptors
-
DOI 10.1038/nm0603-669
-
Ferrara, N., Gerber, H. P. & LeCouter, J. The biology of VEGF and its receptors. Nat. Med. 9, 669-676 (2003). (Pubitemid 36749215)
-
(2003)
Nature Medicine
, vol.9
, Issue.6
, pp. 669-676
-
-
Ferrara, N.1
Gerber, H.-P.2
LeCouter, J.3
-
7
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
DOI 10.1056/NEJMoa032691
-
Hurwitz, H. et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350, 2335-2342 (2004). (Pubitemid 38702844)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.23
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
Cartwright, T.4
Hainsworth, J.5
Heim, W.6
Berlin, J.7
Baron, A.8
Griffing, S.9
Holmgren, E.10
Ferrara, N.11
Fyfe, G.12
Rogers, B.13
Ross, R.14
Kabbinavar, F.15
-
8
-
-
79955829332
-
Development of second-generation VEGFR tyrosine kinase inhibitors: Current status
-
Bhargava, P. & Robinson, M. O. Development of second-generation VEGFR tyrosine kinase inhibitors: current status. Curr. Oncol. Rep. 13, 103-11 (2011).
-
(2011)
Curr. Oncol. Rep.
, vol.13
, pp. 103-111
-
-
Bhargava, P.1
Robinson, M.O.2
-
9
-
-
84866693927
-
Controlling escape from angiogenesis inhibitors
-
Sennino, B. McDonald, D. M. Controlling escape from angiogenesis inhibitors. Nat. Rev. Cancer. 12, 699-709 (2012).
-
(2012)
Nat. Rev. Cancer.
, vol.12
, pp. 699-709
-
-
Sennino, B.1
Mcdonald, D.M.2
-
10
-
-
79960096827
-
Normalization of the vasculature for treatment of cancer and other diseases
-
Goel, S. et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91, 1071-1121 (2011).
-
(2011)
Physiol. Rev.
, vol.91
, pp. 1071-1121
-
-
Goel, S.1
-
11
-
-
84863889456
-
Mind the gap: Potential for rebounds during antiangiogenic treatment breaks
-
Ebos, J. M. & Pili, R. Mind the gap: potential for rebounds during antiangiogenic treatment breaks. Clin. Cancer Res. 18, 3719-21 (2012).
-
(2012)
Clin. Cancer Res.
, vol.18
, pp. 3719-3721
-
-
Ebos, J.M.1
Pili, R.2
-
12
-
-
58149190795
-
Pathways mediating resistance to vascular endothelial growth factor-targeted therapy
-
Ellis, L. M. & Hicklin, D. J. Pathways mediating resistance to vascular endothelial growth factor-targeted therapy. Clin. Cancer Res. 14, 6371-6375 (2008).
-
(2008)
Clin. Cancer Res.
, vol.14
, pp. 6371-6375
-
-
Ellis, L.M.1
Hicklin, D.J.2
-
13
-
-
58649124493
-
A dialogue between the hypoxia-inducible factor and the tumor microenvironment
-
Dayan, F., Mazure, N. M., Brahimi-Horn, C. & Pouyssegur, J. A dialogue between the hypoxia-inducible factor and the tumor microenvironment. Cancer Microenv. 1, 53-68 (2008).
-
(2008)
Cancer Microenv
, vol.1
, pp. 53-68
-
-
Dayan, F.1
Mazure, N.M.2
Brahimi-Horn, C.3
Pouyssegur, J.4
-
14
-
-
84883490063
-
Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
-
Semenza, G. L. Cancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis. Oncogene 32, 4057-4063 (2013).
-
(2013)
Oncogene
, vol.32
, pp. 4057-4063
-
-
Semenza, G.L.1
-
15
-
-
34547124062
-
Hypoxia: A key regulator of angiogenesis in cancer
-
DOI 10.1007/s10555-007-9066-y, Special issue on Hypoxia and Cancer, Guest Editor: Gregg L. Semenza
-
Liao, D. & Johson, R. S.Hypoxia: a key regulator of angiogenesis in cancer. Cancer Met. Rev. 26, 281-290 (2007). (Pubitemid 47101669)
-
(2007)
Cancer and Metastasis Reviews
, vol.26
, Issue.2
, pp. 281-290
-
-
Liao, D.1
Johnson, R.S.2
-
16
-
-
40949142209
-
The role of hypoxia-inducible factors in tumorigenesis
-
DOI 10.1038/cdd.2008.21, PII CDD200821, The biology of Hypoxia-inducible factors
-
Rankin, E. B. & Giaccia, A. J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15, 678-685 (2008). (Pubitemid 351405072)
-
(2008)
Cell Death and Differentiation
, vol.15
, Issue.4
, pp. 678-685
-
-
Rankin, E.B.1
Giaccia, A.J.2
-
17
-
-
58149478525
-
HIF-1alpha and HIF-2alpha have divergent roles in colon cancer
-
Imamura, T. et al. HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int. J. Cancer. 124, 763-771 (2009).
-
(2009)
Int. J. Cancer.
, vol.124
, pp. 763-771
-
-
Imamura, T.1
-
18
-
-
4344692045
-
Constitutive and inducible expression and regulation of vascular endothelial growth factor
-
DOI 10.1016/j.cytogfr.2004.04.003, PII S1359610104000413
-
Xie, K., Wei, D., Shi, Q. & Huang, S. Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine & Growth Factor Rev. 15, 297-324 (2004). (Pubitemid 39140697)
-
(2004)
Cytokine and Growth Factor Reviews
, vol.15
, Issue.5
, pp. 297-324
-
-
Xie, K.1
Wei, D.2
Shi, Q.3
Huang, S.4
-
19
-
-
84655161946
-
HIF1a and HIF2a: Sibling rivalry in hypoxic tumour growth and progression
-
Keith, B., Johnson, R. S. & Simon, M. C. HIF1a and HIF2a: sibling rivalry in hypoxic tumour growth and progression. http://www.ncbi.nlm.nih.gov/ pubmed/22169972 Nat Rev. Cancer. 12, 9-22 (2011).
-
(2011)
Nat Rev. Cancer.
, vol.12
, pp. 9-22
-
-
Keith, B.1
Johnson, R.S.2
Simon, M.C.3
-
20
-
-
33745303045
-
Hypoxia signalling in cancer and approaches to enforce tumour regression
-
DOI 10.1038/nature04871, PII NATURE04871
-
Pouyssegur, J., Dayan, F. & Mazure, N. M. Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature. 441, 437-443 (2006). (Pubitemid 44050138)
-
(2006)
Nature
, vol.441
, Issue.7092
, pp. 437-443
-
-
Pouyssegur, J.1
Dayan, F.2
Mazure, N.M.3
-
21
-
-
84860420398
-
FoxO family members in cancer
-
Zhang, Y., Gan, B., Liu, D. & Paik, J. H. FoxO family members in cancer. Cancer Biol. Ther. 12, 253-259 (2011).
-
(2011)
Cancer Biol. Ther.
, vol.12
, pp. 253-259
-
-
Zhang, Y.1
Gan, B.2
Liu, D.3
Paik, J.H.4
-
22
-
-
0033954247
-
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia- inducible factor 1α
-
Ravi, R. et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor I alpha. Genes Dev. 14, 34-44 (2000). (Pubitemid 30051577)
-
(2000)
Genes and Development
, vol.14
, Issue.1
, pp. 34-44
-
-
Ravi, R.1
Mookerjee, B.2
Bhujwalla, Z.M.3
Sutter, C.H.4
Artemov, D.5
Zeng, Q.6
Dillehay, L.E.7
Madan, A.8
Semenza, G.L.9
Bedi, A.10
-
24
-
-
0035917313
-
2 sensing
-
Ivan, M. et al. HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 292, 464-468 (2001). (Pubitemid 32335941)
-
(2001)
Science
, vol.292
, Issue.5516
, pp. 464-468
-
-
Ivan, M.1
Kondo, K.2
Yang, H.3
Kim, W.4
Valiando, J.5
Ohh, M.6
Salic, A.7
Asara, J.M.8
Lane, W.S.9
Kaelin Jr., W.G.10
-
25
-
-
0033566693
-
Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2
-
Feldser, D. et al. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res. 95, 3915-3918 (1999). (Pubitemid 29393552)
-
(1999)
Cancer Research
, vol.59
, Issue.16
, pp. 3915-3918
-
-
Feldser, D.1
Agani, F.2
Iyer, N.V.3
Pak, B.4
Ferreira, G.5
Semenza, G.L.6
-
26
-
-
0034654174
-
Modulation of hypoxia-inducible factor 1α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
-
Zhong, H. et al.Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541-1545 (2000). (Pubitemid 30183422)
-
(2000)
Cancer Research
, vol.60
, Issue.6
, pp. 1541-1545
-
-
Zhong, H.1
Chiles, K.2
Feldser, D.3
Laughner, E.4
Hanrahan, C.5
Georgescu, M.-M.6
Simons, J.W.7
Semenza, G.L.8
-
27
-
-
0242331755
-
HIF-1 as a target for drug development
-
Giaccia, A., Bronwyn,G. S.& Randall, S. J. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2, 803-811 (2003). (Pubitemid 37361812)
-
(2003)
Nature Reviews Drug Discovery
, vol.2
, Issue.10
, pp. 803-811
-
-
Giaccia, A.1
Siim, B.G.2
Johnson, R.S.3
-
28
-
-
70549105123
-
Integrins as functional hubs" the regulation of pathological angiogenesis
-
Contois, L., Akalu, A. & Brooks, P. C. Integrins as "functional hubs" in the regulation of pathological angiogenesis. Semin. Cancer Biol. 19, 318-328 (2009).
-
(2009)
Semin. Cancer Biol.
, vol.19
, pp. 318-328
-
-
Contois, L.1
Akalu, A.2
Brooks, P.C.3
-
29
-
-
77954685078
-
Integrins and signal transduction
-
Cabodi, S. et al. Integrins and signal transduction. Adv. Exp. Med. Biol. 674, 43-54 (2010).
-
(2010)
Adv. Exp. Med. Biol.
, vol.674
, pp. 43-54
-
-
Cabodi, S.1
-
30
-
-
0036774111
-
Integrin-associated proteins
-
DOI 10.1016/S0955-0674(02)00360-5
-
Brown, E. J. Integrin-associated proteins. Curr. Opin. Cell Biol. 14, 603-607 (2002). (Pubitemid 35247744)
-
(2002)
Current Opinion in Cell Biology
, vol.14
, Issue.5
, pp. 603-607
-
-
Brown, E.J.1
-
31
-
-
33751334377
-
Complex functional interaction between integrin receptors and ion channels
-
DOI 10.1016/j.tcb.2006.10.003, PII S096289240600273X
-
Arcangeli, A. & Becchetti, A. Complex functional interaction between integrin receptors and ion channels. Trends Cell Biol. 16, 631-639 (2006). (Pubitemid 44809885)
-
(2006)
Trends in Cell Biology
, vol.16
, Issue.12
, pp. 631-639
-
-
Arcangeli, A.1
Becchetti, A.2
-
32
-
-
77957923427
-
-
Jeon K. W. (ed) Elsevier
-
Becchetti, A., Pillozzi, S., Morini, R.,Nesti, E. & Arcangeli, A. New insights into the regulation of ion channels by integrins. Jeon, K. W. (ed) 135-190 (Elsevier, 2010).
-
(2010)
New Insights into the Regulation of Ion Channels by Integrins
, pp. 135-190
-
-
Becchetti, A.1
Pillozzi, S.2
Morini, R.3
Nesti, E.4
Arcangeli, A.5
-
33
-
-
48649099004
-
A comment on ion channels as pharmacological targets in oncology
-
Becchetti, A. & Arcangeli, A. A comment on ion channels as pharmacological targets in oncology. J. Gen. Physiol. 132, 313-314 (2008).
-
(2008)
J. Gen. Physiol.
, vol.132
, pp. 313-314
-
-
Becchetti, A.1
Arcangeli, A.2
-
34
-
-
44649159442
-
Ion channels: Functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer
-
DOI 10.1038/embor.2008.75, PII EMBOR200875
-
Fraser, S. P. & Pardo, L. A. Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer. EMBO Rep. 9, 512-515 (2008). (Pubitemid 351772910)
-
(2008)
EMBO Reports
, vol.9
, Issue.6
, pp. 512-515
-
-
Fraser, S.P.1
Pardo, L.A.2
-
35
-
-
61949377514
-
Targeting ion channels in cancer: A novel frontier in antineoplastic therapy
-
Arcangeli, A. et al. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 16, 66-93 (2009).
-
(2009)
Curr. Med. Chem.
, vol.16
, pp. 66-93
-
-
Arcangeli, A.1
-
36
-
-
79961003531
-
American Journal of Physiology-Cell Physiology theme: Ion channels and transporters in cancer
-
Arcangeli, A. & Yuan, J. X. American Journal of Physiology-Cell Physiology theme: ion channels and transporters in cancer. Am. J. Physiol. Cell. Physiol. 301, C253-4 (2011).
-
(2011)
Am. J. Physiol. Cell. Physiol.
, vol.301
-
-
Arcangeli, A.1
Yuan, J.X.2
-
38
-
-
77954664903
-
Physical and functional interaction between integrins and Herg1 channels in cancer cells
-
Pillozzi, S. & Arcangeli, A. Physical and functional interaction between integrins and Herg1 channels in cancer cells. Adv. Exp. Med. Biol. 674, 55-67 (2010).
-
(2010)
Adv. Exp. Med. Biol.
, vol.674
, pp. 55-67
-
-
Pillozzi, S.1
Arcangeli, A.2
-
39
-
-
21144435502
-
1 integrins and modulate adhesion-dependent signaling
-
DOI 10.1091/mbc.E04-10-0940
-
Cherubini, A. et al. Human ether-a-go-go-related gene 1 channels are physically linked to b1 integrins and modulate adhesion-dependent signaling. Mol. Biol. Cell. 6, 2972-2983 (2005). (Pubitemid 40741240)
-
(2005)
Molecular Biology of the Cell
, vol.16
, Issue.6
, pp. 2972-2983
-
-
Cherubini, A.1
Hofmann, G.2
Pillozzi, S.3
Guasti, L.4
Crociani, O.5
Cilia, E.6
Di Stefano, P.7
Degani, S.8
Balzi, M.9
Olivotto, M.10
Wanke, E.11
Becchetti, A.12
Defilippi, P.13
Wymore, R.14
Arcangeli, A.15
-
40
-
-
34548036519
-
+ channel for a macromolecular signaling complex in acute myeloid leukemia: Role in cell migration and clinical outcome
-
DOI 10.1182/blood-2006-02-003772
-
Pillozzi, S. et al. VEGFR-1 (FLT-1), beta1 integrin, and hERG K1 channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome. Blood. 110, 1238-1250 (2007). (Pubitemid 47281422)
-
(2007)
Blood
, vol.110
, Issue.4
, pp. 1238-1250
-
-
Pillozzi, S.1
Brizzi, M.F.2
Bernabei, P.A.3
Bartolozzi, B.4
Caporale, R.5
Basile, V.6
Boddi, V.7
Pegoraro, L.8
Becchetti, A.9
Arcangeli, A.10
-
41
-
-
78751689287
-
Chemotherapy resistance in acute lymphoblastic leukemia requires Herg1 channels and is overcome by Herg1 blockers
-
Pillozzi, S. et al. Chemotherapy resistance in acute lymphoblastic leukemia requires Herg1 channels and is overcome by Herg1 blockers. Blood. 117, 902-914 (2011).
-
(2011)
Blood
, vol.117
, pp. 902-914
-
-
Pillozzi, S.1
-
42
-
-
27144531556
-
Herg1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines
-
DOI 10.1038/sj.bjc.6602775, PII 6602775
-
Masi, A. et al. Herg1 channels are overexpressed in glioblastomamultiforme and modulate VEGF secretion in glioblastoma cell lines. Brit. J. Canc. 93, 781-792 (2005). (Pubitemid 41486438)
-
(2005)
British Journal of Cancer
, vol.93
, Issue.7
, pp. 781-792
-
-
Masi, A.1
Becchetti, A.2
Restano-Cassulini, R.3
Polvani, S.4
Hofmann, G.5
Buccoliero, A.M.6
Paglierani, M.7
Pollo, B.8
Taddei, G.L.9
Gallina, P.10
Di Lorenzo, N.11
Franceschetti, S.12
Wanke, E.13
Arcangeli, A.14
-
43
-
-
9144274941
-
Herg1 Gene and Herg1 Protein Are Overexpressed in Colorectal Cancers and Regulate Cell Invasion of Tumor Cells
-
DOI 10.1158/0008-5472.CAN-03-2360
-
Lastraioli, E. et al. Herg1 gene and Herg1 protein are overexpressed in colorectal cancers and regulate cell invasion of tumor cells. Cancer Res. 15, 606-611 (2004). (Pubitemid 38120900)
-
(2004)
Cancer Research
, vol.64
, Issue.2
, pp. 606-611
-
-
Lastraioli, E.1
Guasti, L.2
Crociani, O.3
Polvani, S.4
Hofmann, G.5
Witchel, H.6
Bencini, L.7
Calistri, M.8
Messerini, L.9
Scatizzi, M.10
Moretti, R.11
Wanke, E.12
Olivotto, M.13
Mugnai, G.14
Arcangeli, A.15
-
44
-
-
84859448786
-
Herg1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage i and II Colorectal Cancer: A Pilot Study
-
Lastraioli, E. et al. Herg1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study. Transl. Oncol. 5, 105-112 (2012).
-
(2012)
Transl. Oncol.
, vol.5
, pp. 105-112
-
-
Lastraioli, E.1
-
45
-
-
0027254699
-
Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels
-
Arcangeli, A. et al. Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels. J. Cell Biol. 122, 1131-1143 (1993). (Pubitemid 23254179)
-
(1993)
Journal of Cell Biology
, vol.122
, Issue.5
, pp. 1131-1143
-
-
Arcangeli, A.1
Becchetti, A.2
Mannini, A.3
Mugnai, G.4
De Filippi, P.5
Tarone, G.6
Del Bene, M.R.7
Barletta, E.8
Wanke, E.9
Olivotto, M.10
-
46
-
-
0035895887
-
HERG K1 channels activation during beta(1) integrinmediated adhesion to fibronectin induces an up-regulation of alpha(v)beta(3) integrin in the preosteoclastic leukemia cell line FLG 29.1
-
Hofmann, G. et al. HERG K1 channels activation during beta(1) integrinmediated adhesion to fibronectin induces an up-regulation of alpha(v)beta(3) integrin in the preosteoclastic leukemia cell line FLG 29.1. J. Biol. Chem. 276, 4923-4931 (2001).
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 4923-4931
-
-
Hofmann, G.1
-
47
-
-
0034100051
-
In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002)
-
Hu, L., Zaloudek, C.,Mills, G. B., Gray, J. & Jaffe, R. B. In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin. Cancer Res. 6, 880-886 (2000). (Pubitemid 30159344)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.3
, pp. 880-886
-
-
Hu, L.1
Zaloudek, C.2
Mills, G.B.3
Gray, J.4
Jaffe, R.B.5
-
48
-
-
2542547908
-
Perifosine a novel alkylphospholipid, inhibits protein kinase B activation
-
Kondapaka, S. B., Singh, S. S., Dasmahapatra, G. P., Sausville, E. A. & Roy, K. K. Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol. Cancer Ther. 2, 1093-1103 (2003).
-
(2003)
Mol. Cancer Ther.
, vol.2
, pp. 1093-1103
-
-
Kondapaka, S.B.1
Singh, S.S.2
Dasmahapatra, G.P.3
Sausville, E.A.4
Roy, K.K.5
-
49
-
-
34547134517
-
Hypoxia-inducible factor 1α is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif
-
DOI 10.1074/jbc.M611782200
-
Land, S. C. & Tee, A. R. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J. Biol. Chem http://www.ncbi.nlm.nih.gov/pubmed/17502379. 282, 20534-20543 (2007). (Pubitemid 47100043)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.28
, pp. 20534-20543
-
-
Land, S.C.1
Tee, A.R.2
-
50
-
-
33745003285
-
Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB
-
DOI 10.1042/BJ20051839
-
Frede, S., Stockmann, C., Freitag, P. & Fandrey, J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kB. Biochem. J. 396, 517-527 (2006). (Pubitemid 44228166)
-
(2006)
Biochemical Journal
, vol.396
, Issue.3
, pp. 517-527
-
-
Frede, S.1
Stockmann, C.2
Freitag, P.3
Fandrey, J.4
-
51
-
-
37049002653
-
Shypoxia up-regulates hypoxia-inducible factor-1atranscription by involving phosphatidylinositol 3-kinase and nuclear factor kB in pulmonary artery smooth muscle cells
-
Belaiba, R. et al. S.Hypoxia up-regulates hypoxia-inducible factor-1atranscription by involving phosphatidylinositol 3-kinase and nuclear factor kB in pulmonary artery smooth muscle cells. Mol. Biol. Cell. 18, 4691-4697 (2007).
-
(2007)
Mol. Biol. Cell.
, vol.18
, pp. 4691-4697
-
-
Belaiba, R.1
-
52
-
-
44849100198
-
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
-
DOI 10.1038/nature06905, PII NATURE06905
-
Rius, J. et al. NF-kB links innate immunity to the hypoxic response through transcriptional regulation of HIF 1a. Nature. 453, 807-811 (2008). (Pubitemid 351793778)
-
(2008)
Nature
, vol.453
, Issue.7196
, pp. 807-811
-
-
Rius, J.1
Guma, M.2
Schachtrup, C.3
Akassoglou, K.4
Zinkernagel, A.S.5
Nizet, V.6
Johnson, R.S.7
Haddad, G.G.8
Karin, M.9
-
53
-
-
70249099576
-
Interdependence of hypoxic and innate immune responses
-
Nizet, V. & Johnson, R. S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609-617 (2009).
-
(2009)
Nat. Rev. Immunol.
, vol.9
, pp. 609-617
-
-
Nizet, V.1
Johnson, R.S.2
-
54
-
-
2942590732
-
Exploiting tumour hypoxia in cancer treatment
-
Brown, J. M. & Wilson, W. R. Exploiting tumour hypoxia in cancer treatment. Nat. Rev. Cancer. 4, 437-447 (2004). (Pubitemid 38745529)
-
(2004)
Nature Reviews Cancer
, vol.4
, Issue.6
, pp. 437-447
-
-
Brown, J.M.1
Wilson, W.R.2
-
55
-
-
79960024581
-
Reciprocal influence of the p53 and the hypoxic pathways
-
Sermeus, A. & Michiels, C. Reciprocal influence of the p53 and the hypoxic pathways. Cell death and disease. 2 e164 (2011).
-
(2011)
Cell Death and Disease
, vol.2
-
-
Sermeus, A.1
Michiels, C.2
-
56
-
-
0032553485
-
2 arrest after DNA damage
-
Bunz, F. et al. Requirement for p53 and p21 to Sustain G2 Arrest After DNA Damage. Science. 282, 1497-1501 (1998). (Pubitemid 28538613)
-
(1998)
Science
, vol.282
, Issue.5393
, pp. 1497-1501
-
-
Bunz, F.1
Dutriaux, A.2
Lengauer, C.3
Waldman, T.4
Zhou, S.5
Brown, J.P.6
Sedivy, J.M.7
Kinzler, K.W.8
Vogelstein, B.9
-
57
-
-
84863754907
-
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex
-
Lu, K. V. et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 22, 21-35 (2012).
-
(2012)
Cancer Cell
, vol.22
, pp. 21-35
-
-
Lu, K.V.1
-
58
-
-
0033045434
-
Functional role of the slow activation property of ERG K1 channels
-
Schönherr, R. et al. Functional role of the slow activation property of ERG K1 channels. Eur J. Neurosci. 11, 753-760 (1999).
-
(1999)
Eur J. Neurosci.
, vol.11
, pp. 753-760
-
-
Schönherr, R.1
-
59
-
-
0026649343
-
Intra and extracellular surface charges near Ca21 channels in neurons and neuroblastoma cells
-
Becchetti, A., Arcangeli, A., Del Bene, M. R., Olivotto, M. Wanke, E. Intra and extracellular surface charges near Ca21 channels in neurons and neuroblastoma cells. Biophys J. 63, 954-965 (1992).
-
(1992)
Biophys J.
, vol.63
, pp. 954-965
-
-
Becchetti, A.1
Arcangeli, A.2
Del Bene, M.R.3
Olivotto, M.4
Wanke, E.5
-
60
-
-
0037073695
-
Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms
-
Pagé, E. L., Chan, D. A., Giaccia, A. J., Levine, M. & Richard, D. E. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem http://www.ncbi.nlm.nih.gov/pubmed/ 12379645. 277, 48403-48409 (2007).
-
(2007)
J. Biol. Chem
, vol.277
, pp. 48403-48409
-
-
Pagé, E.L.1
Chan, D.A.2
Giaccia, A.J.3
Levine, M.4
Richard, D.E.5
-
61
-
-
33746899015
-
Akt1 activation can augment hypoxia-inducible factor-1α expression by increasing protein translation through a mammalian target of rapamycin-independent pathway
-
DOI 10.1158/1541-7786.MCR-05-0234
-
Pore, N. et al. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol. Cancer Res. 4, 471-479 (2006). (Pubitemid 44197042)
-
(2006)
Molecular Cancer Research
, vol.4
, Issue.7
, pp. 471-479
-
-
Pore, N.1
Jiang, Z.2
Shu, H.-K.3
Bernhard, E.4
Kao, G.D.5
Maity, A.6
-
62
-
-
77952424136
-
Cross talk between stimulated NF-kappaB and the tumor suppressor p53
-
Schneider, G. et al. Cross talk between stimulated NF-kappaB and the tumor suppressor p53. Oncogene. 29, 2795-806 (2010).
-
(2010)
Oncogene
, vol.29
, pp. 2795-2806
-
-
Schneider, G.1
-
63
-
-
84888880067
-
Characterization of Herg1 channel role in mouse colorectal carcinogenesis
-
Fiore, A. et al. Characterization of Herg1 channel role in mouse colorectal carcinogenesis. Cancer Med 2, 583-594 (2013).
-
(2013)
Cancer Med
, vol.2
, pp. 583-594
-
-
Fiore, A.1
-
64
-
-
84875422081
-
Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
-
D'Amico, M., Gasparoli, L. & Arcangeli, A. Potassium channels: novel emerging biomarkers and targets for therapy in cancer. Recent Pat. Anticancer Drug Discov. 8, 53-65 (2013).
-
(2013)
Recent Pat. Anticancer Drug Discov.
, vol.8
, pp. 53-65
-
-
D'Amico, M.1
Gasparoli, L.2
Arcangeli, A.3
|